Corynecin II (CAS 35098-52-3)

Corynecin II is an antibiotic compound known for its role as an inhibitor of protein synthesis in bacterial cells. It functions by binding to the bacterial ribosome, specifically targeting the peptidyl transferase center, thereby obstructing the elongation phase of protein synthesis. This action prevents the formation of peptide bonds between amino acids, effectively halting the production of essential proteins required for bacterial growth and survival. Corynecin II has been utilized extensively in microbiological and biochemical research to explore the mechanisms of protein synthesis and the effects of its inhibition on bacterial physiology. Research involving Corynecin II has provided significant insights into the intricacies of ribosomal function and the development of bacterial resistance mechanisms. Studies have employed this compound to dissect the molecular interactions within the ribosome, enhancing the understanding of how antibiotics can selectively target bacterial protein synthesis without affecting eukaryotic cells. Additionally, Corynecin II serves as a valuable tool in investigating the genetic and biochemical bases of antibiotic resistance, helping to identify mutations in ribosomal components that confer resistance. These investigations contribute to a broader understanding of bacterial adaptation and survival strategies under antibiotic pressure, which is crucial for the development of new strategies to combat bacterial infections. Corynecin II′s specific targeting of the ribosome underscores its importance in fundamental research on protein synthesis and antibiotic action.